The US FDA has warned people not to use a $30 DIY epinephrine delivery device developed after Mylan increased the price of the Epipen.
Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.
Clot busting drugs derived from human urine are no more likely to be contaminated with Zika virus than other medicines according to research by the EMA.
Sartorius Stedim Biotech claims it has a platform that can help biopharma companies carve months off the development time for new products.
Moderna Therapeutics has announced plans for a $110m (€98m) API manufacturing facility for its pipeline of mRNA therapeutics.
Banned API firm Hebei Yuxing Bio-Engineering has had a microbial contamination problem at its plant since 2013 according to the US FDA.